Phathom Pharmaceuticals, Inc. ( PHAT) - Key Metrics
PHAT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.89 | -$0.21 | -$0.02 | -$0.02 |
| 2026Q1 | $0.71 | -$0.37 | -$0.19 | -$0.19 |
| 2025Q4 | $0.78 | -$0.29 | -$0.07 | -$0.07 |
| 2025Q3 | $0.67 | -$0.41 | -$0.19 | -$0.19 |
| 2025Q2 | $0.55 | -$1.05 | -$0.87 | -$0.87 |
PHAT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -12.92 |
| 2026Q1 | 0% | -7.51 |
| 2025Q4 | 0% | -14.30 |
| 2025Q3 | 0% | -7.18 |
| 2025Q2 | 0% | -2.28 |
PHAT
Price: $9.57
52 week price:
Earnings Per Share: -1.22 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 521200
Market Capitalization: 665.8 million